Author:
Peat Judy,Frazee Clint,Garg Uttam
Reference14 articles.
1. Broussard LA (2007) Monitoring anticonvulsants concentrations: general considerations. In: Hammett-Stabler CA, Dasgupta A (eds) Therapeutic drug monitoring data. AACC Press, Washington, D.C., pp 41–75
2. Moyer TP, Shaw LM (2006) Therapeutic drugs and their management. In: Burtis CA, Ashwood ER, Bruns DE (eds) Tietz textbook of clinical chemistry and molecular diagnostics, 4th edn. Elsevier Saunders, St. Louis, MO, pp 1237–1285
3. Biddle DA, Wells A, Dasgupta A (2000) Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALDI mass spectrometric determination of molecular weight range of inhibitors. Life Sci 66:143–151
4. Wolf GK, McClain CD, Zurakowski D, Dodson B, McManus ML (2006) Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children. Pediatr Crit Care Med 7:434–439, quiz 440
5. Bardin S, Ottinger JC, Breau AP, O’Shea TJ (2000) Determination of free levels of phenytoin in human plasma by liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal 23:573–579
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献